Drescher CW - Search Results

1

Development of an ovarian cancer symptom index: possibilities for earlier detection.

Goff BA, Mandel LS, Drescher CW, Urban N, Gough S, Schurman KM, Patras J, Mahony BS, Andersen MR. Goff BA, et al. Among authors: drescher cw. Cancer. 2007 Jan 15;109(2):221-7. doi: 10.1002/cncr.22371. Cancer. 2007. PMID: 17154394 Free article.

2

Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With ERBB2/3 Amplification, Overexpression, or Mutation: Results From the TAPUR Study.

Ahn ER, Rothe M, Mangat PK, Garrett-Mayer E, Ali-Ahmad HM, Chan J, Maitland ML, Patel SR, Reese Z, Balmanoukian AS, Drescher CW, Li R, Tsimberidou AM, Leath CA 3rd, O'Lone R, Grantham GN, Halabi S, Schilsky RL. Ahn ER, et al. Among authors: drescher cw. JCO Precis Oncol. 2023 Apr;7:e2200609. doi: 10.1200/PO.22.00609. JCO Precis Oncol. 2023. PMID: 37027810

3

Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening.

Urban N, Drescher C, Etzioni R, Colby C. Urban N, et al. Control Clin Trials. 1997 Jun;18(3):251-70. doi: 10.1016/s0197-2456(96)00233-4. Control Clin Trials. 1997. PMID: 9204225

4

Adenocarcinoma of the uterine cervix metastatic to lymph nodes.

Cohn DE, Peters WA 3rd, Muntz HG, Wu R, Greer BE, Tamimi HK, Drescher CW, Smith MR, Yon JL, Schmidt R, Goff BA. Cohn DE, et al. Among authors: drescher cw. Am J Obstet Gynecol. 1998 Jun;178(6):1131-7. doi: 10.1016/s0002-9378(98)70313-8. Am J Obstet Gynecol. 1998. PMID: 9662291

5

Reported ovarian cancer screening among a population-based sample in Washington state.

Drescher C, Holt SK, Andersen MR, Anderson G, Urban N. Drescher C, et al. Obstet Gynecol. 2000 Jul;96(1):70-4. doi: 10.1016/s0029-7844(00)00849-8. Obstet Gynecol. 2000. PMID: 10862845

6

Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer.

Andersen MR, Peacock S, Nelson J, Wilson S, McIntosh M, Drescher C, Urban N. Andersen MR, et al. Gynecol Oncol. 2002 Apr;85(1):3-8. doi: 10.1006/gyno.2001.6556. Gynecol Oncol. 2002. PMID: 11925113

7

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

Hellström I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, Drescher C, Urban N, Hellström KE. Hellström I, et al. Cancer Res. 2003 Jul 1;63(13):3695-700. Cancer Res. 2003. PMID: 12839961

8

Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.

Drescher CW, Nelson J, Peacock S, Andersen MR, McIntosh MW, Urban N. Drescher CW, et al. Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):600-6. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15066925 Clinical Trial.

9

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma.

McIntosh MW, Drescher C, Karlan B, Scholler N, Urban N, Hellstrom KE, Hellstrom I. McIntosh MW, et al. Gynecol Oncol. 2004 Oct;95(1):9-15. doi: 10.1016/j.ygyno.2004.07.039. Gynecol Oncol. 2004. PMID: 15385104 Free PMC article.

10

Clinical trials: understanding and perceptions of female Chinese-American cancer patients.

Tu SP, Chen H, Chen A, Lim J, May S, Drescher C. Tu SP, et al. Cancer. 2005 Dec 15;104(12 Suppl):2999-3005. doi: 10.1002/cncr.21524. Cancer. 2005. PMID: 16247796 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page